EUVIMEDObjevte EUVIMED
Delphi-StudieOpen access

Ethics of Autonomous AI Clinical Trials: Delphi Study

Ethik autonomer KI-Studien: Delphi-Studie

Ariadne A Nichol, Alaa Youssef, David B Larson, Michael Abramoff, Risa M Wolf, Danton Char, Nicole Martinez-Martin

Journal of Medical Internet Research · 2026-08-21 · 28 · e91472-e91472

DOI: 10.2196/91472 ↗

Auf einen Blick

Eine Delphi-Expert:innenrunde erarbeitete Empfehlungen zur Anwendung der 7 NIH-Prinzipien auf klinische Studien mit autonomer KI. Im Fokus standen Transparenz, Bias, Leistung in verschiedenen Versorgungskontexten und Einwilligung.

Fragestellung

Wie sollen die 7 NIH-Prinzipien ethischer klinischer Forschung auf klinische Studien mit autonomer KI angewendet werden?

Methode

Modifizierte Delphi-Studie mit 2 Befragungsrunden und finalem virtuellem Treffen; multidisziplinäres Expert:innengremium.

Ergebnisse

14 Expert:innen nahmen teil. In Runde 2 ergaben sich 9 Aussagen mit starker Zustimmung, 2 mit moderater Zustimmung und 4 kontroverse Aussagen. Die Schlussrunde führte zu Empfehlungen zu Transparenz, Bias, Einwilligung und Zugang.

Schlussfolgerung der Autor:innen

Die ethische Bewertung autonomer KI-Studien sollte über technische Genauigkeit hinausgehen, um potenzielle Schäden für Patient:innen zu mindern. Die Empfehlungen können künftige Forschung, Politik und Leitlinien informieren.

Kernaussagen

  • 14 Expert:innen in einer Delphi-Studie
  • 9 starke und 2 moderate Zustimmungsaussagen in Runde 2
  • Empfehlungen zu Transparenz, Bias, Einwilligung und Zugang

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

At a glance

Delphi-Studie in Journal of Medical Internet Research, published online on 2026-08-21. Written by Ariadne A Nichol and 6 co-authors. Institution: Center for Biomedical Ethics, Stanford Medicine, 300 Pasteur Drive, Stanford, CA, 94305, United States, 1 (650) 723-4480. Major MEDLINE topics: Artificial Intelligence, Clinical Trials as Topic. Cited 2 times so far (Crossref); 35 references. The full text is freely available in PubMed Central. Funded by: NEI NIH HHS.

Auf einen BlickAbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Background

Safe implementation of autonomous AI in medicine requires rigorous evaluation through clinical trials. The 7 guiding principles for ethical clinical research endorsed by the National Institutes of Health (NIH) provide an established framework for promoting scientific rigor and protecting the safety of human participants. However, clinical trials of autonomous AI raise novel ethical issues that require adaptation of these principles to account for effects that can vary across stakeholders and implementation contexts, including model performance across clinical settings. Incorporating expert perspectives on such challenges is critical to developing effective and ethically robust guidelines for autonomous AI clinical trials.

Objective

This Delphi study aimed to generate expert consensus on how the National Institutes of Health’s 7 principles of ethical clinical research should be applied to clinical trials of autonomous AI.

Methods

We conducted 2 rounds of surveys followed by a final virtual meeting using a modified Delphi approach with a multidisciplinary expert panel. Participants were purposively identified through PubMed literature searches and selected for expertise in AI, data science, ophthalmology, public policy, law, bioethics, and patient advocacy. Round 1 used open-ended survey questions based on a vignette describing an autonomous AI tool. Round 1 survey responses were analyzed qualitatively using thematic coding, and were used to generate representative statements for Round 2. In round 2, panelists rated statements on a 5-point Likert scale. In accordance with Delphi methodology, statements of consensus within the surveys (at least 80% rating agreement) and moderate agreement (60%‐80% rating agreement) were identified for further discussion and iteration. Findings from a final virtual meeting were then analyzed thematically and synthesized into actionable recommendations.

Results

Fourteen expert panelists participated in the Delphi study over a 6-month period. Participation was 12 (85.7%) of 14 experts in round 1, 10 (71.4%) of 14 experts in round 2, and 13 (92.9%) of 14 experts in the final virtual meeting. Round 2 survey results yielded 9 strong agreement statements, 2 moderate agreement statements, and 4 divisive statements for participants to explore further in developing recommendations. Final recommendations from the virtual meeting addressed transparency regarding training and validation data, bias assessment before deployment, performance across clinical settings, health inequities before implementation, stakeholder engagement, informed consent, comparison of AI tools with existing standards of care, downstream access to care after AI-generated recommendations, and cost and access implications.

Conclusions

Ethical evaluation of autonomous AI clinical trials should extend beyond technical accuracy to help mitigate potential harms to patients. This study highlights key ethical considerations for clinical trials of autonomous AI and provides consensus recommendations from a multidisciplinary Delphi panel. These recommendations can inform future research, policy, and guidance for the ethical development and implementation of autonomous AI clinical trials.

Subjects

MeSH terms (MEDLINE)

Artificial IntelligenceClinical Trials as TopicDelphi TechniqueHumansUnited States

Author keywords

Delphiautonomous AIbioethicsclinical trialconsensusethicspublic policytransparency

Authors and institutions

  • Center for Biomedical Ethics, Stanford Medicine, 300 Pasteur Drive, Stanford, CA, 94305, United States, 1 (650) 723-4480.
  • Department of Radiology, Stanford Medicine, Stanford, CA, United States.
  • Department of Ophthalmology and Visual Sciences, University of Iowa Health Care, Iowa City, IA, United States.
  • Department of Pediatrics, Division of Endocrinology, Johns Hopkins Medicine, Baltimore, MD, United States.
  • Department of Anesthesiology, Division of Pediatric Cardiac Anesthesia, Stanford Medicine, Stanford, CA, United States.
  • Department of Psychiatry and Behavioral Sciences, Stanford Medicine, Stanford, CA, United States.

Funding

  • NEI NIH HHS

Cite

APA

Nichol, A. A., Youssef, A., Larson, D. B., Abramoff, M., Wolf, R. M., Char, D., & Martinez-Martin, N. (2026). Ethics of Autonomous AI Clinical Trials: Delphi Study. Journal of Medical Internet Research, 28, e91472-e91472. https://doi.org/10.2196/91472

Vancouver

Nichol AA, Youssef A, Larson DB, Abramoff M, Wolf RM, Char D, et al. Ethics of Autonomous AI Clinical Trials: Delphi Study. Journal of Medical Internet Research. 2026;28:e91472-e91472. doi:10.2196/91472

BibTeX
@article{Nichol2026,
  author = {Nichol, Ariadne A and Youssef, Alaa and Larson, David B and Abramoff, Michael and Wolf, Risa M and Char, Danton and Martinez-Martin, Nicole},
  title = {Ethics of Autonomous AI Clinical Trials: Delphi Study},
  journal = {Journal of Medical Internet Research},
  year = {2026},
  volume = {28},
  pages = {e91472--e91472},
  doi = {10.2196/91472}
}
Start for free →